Stories

Growing debate is emerging around how nicotine is perceived in public health discussions, with some commentators arguing that it is often wrongly identified as the primary cause of smoking-related harm. The central claim is that it is the act of combustion—burning tobacco—that produces the vast majority of toxic chemicals responsible for disease, rather than nicotine itself. This perspective suggests that conflating nicotine with smoking risks misleading the public and obscuring the potential role of lower-risk alternatives in reducing harm. Proponents argue that clearer communication around relative risks could support more effective strategies to reduce smoking-related illness. At the same time, the issue remains contentious, particularly given nicotine’s addictive nature and concerns about uptake among non-smokers. The discussion reflects a broader divide in public health between precautionary approaches and harm reduction strategies.

France has introduced one of the strictest approaches in Europe to nicotine pouches, with new rules criminalising not only their sale but also personal possession and use. As of April 2026, these products are classified as a “toxic substance” under a health ministry decree, placing them under severe legal restrictions. Unlike in most other countries, individuals found in possession of nicotine pouches could face significant penalties, including large fines and even prison sentences under existing public health laws. The ban also extends beyond pouches to cover other non-medicinal oral nicotine products, while exempting approved nicotine replacement therapies. This move highlights an increasingly strict regulatory stance in France, and has sparked wider debate about proportionality, enforcement, and the role of alternative nicotine products within public health policy.

Growing concern is emerging in Bangladesh as anti-tobacco organisations warn against proposed changes to national legislation that would remove key restrictions on e-cigarettes. The planned amendments include lifting the ban on these products and allowing the display of tobacco at points of sale, raising fears about increased visibility and access. Health advocates argue that such measures could weaken existing tobacco control efforts and contribute to higher rates of nicotine use, particularly among young people. Critics also stress that emerging nicotine products may act as a gateway to addiction, warning that loosening regulations could open the door to stronger industry influence. The debate highlights broader tensions between regulatory changes and public health priorities in a country already facing a significant burden from tobacco-related harm.

Brazil’s tobacco exports saw a decline in the first two months of 2026, reflecting shifting demand and market conditions in key international destinations. Despite this drop in volume, overall export levels remain above the long-term average, indicating continued resilience in the sector. The country remains one of the world’s leading tobacco exporters, with the majority of production destined for foreign markets. Recent fluctuations are linked in part to changes in demand from major buyers, as well as broader trade dynamics affecting agricultural commodities. While short-term performance has softened, the data suggests that Brazil’s tobacco industry continues to maintain a strong position globally. The trend highlights how export performance can vary in the short term while still remaining stable over a longer horizon.

The GFN26 team has announced that the Global Forum on Nicotine’s online conference programme is now live. A keynote session will take place on Thursday, 4 June 2026 at 09:30 in the main auditorium, where Dr Garrett McGovern, Professor Jean-François Etter and Dr Arielle Selya will discuss the impact of prohibition on health and ethics. Registration is now open, with further details available on the official website.

Sweden has reached a significant public health milestone, with daily smoking rates falling to just 3.7 percent—well below the threshold commonly used to define a “smoke-free” society. This places the country at the forefront of global efforts to reduce smoking prevalence, far ahead of most EU member states. The achievement is often linked to long-term trends showing a steady decline in cigarette use alongside the availability of alternative nicotine products. Sweden has consistently recorded some of the lowest smoking rates in Europe, reinforcing its position as a leading case study in tobacco control. The milestone is now fuelling wider debate about which policies and behavioural shifts have driven this progress, and whether similar approaches could be replicated in other countries.

Growing concern is being raised about a new generation of young people developing nicotine dependence through emerging products such as e-cigarettes and nicotine pouches. Critics argue that these products, often marketed as safer alternatives, may still contribute to addiction among adolescents and young adults. The discussion highlights how early exposure to nicotine increases the risk of long-term dependence, particularly given the vulnerability of the developing brain. At the same time, rising use of newer nicotine formats among youth is fuelling debate over whether current public health strategies are adequately addressing changing patterns of consumption. The issue reflects broader concerns that progress in reducing smoking rates could be offset by the growth of alternative nicotine products.

Growing criticism is emerging around the UK’s Tobacco and Vapes Bill, with some commentators arguing that the legislation could undermine its own public health objectives. Critics claim that measures such as the generational smoking ban and tighter restrictions on alternative nicotine products risk driving consumers towards illicit markets rather than reducing overall harm. Concerns are also being raised about the potential unintended consequences for small retailers and the wider high street, as stricter rules may disproportionately impact legal businesses while leaving illegal trade less affected. The argument centres on whether innovation—particularly the rise of vaping and other alternatives—has already played a significant role in reducing smoking rates without the need for heavy-handed regulation. At the heart of the debate is a broader question about the effectiveness of prohibition-style policies versus harm reduction approaches in achieving long-term public health goals.

The government plans to amend the anti-tobacco ordinance by lifting the ban on e-cigarettes, sparking concerns about public health and youth. The decision follows a recommendation from a special committee reviewing ordinances. Anti-tobacco advocates warn that e-cigarettes are harmful, with 30 countries having banned them. Health experts and campaigners stress the importance of protecting youths and urge the government to reconsider the move. The amendments will also eliminate restrictions on displaying tobacco products at sales points. The ordinance aims to control tobacco use and includes penalties for violation. Public health advocates emphasize the need to maintain restrictions on e-cigarettes and tobacco products to safeguard the population.

The UK Parliament has moved a step closer to finalising the Tobacco and Vapes Bill after accepting amendments introduced by the House of Lords. The changes focus largely on strengthening enforcement mechanisms and refining how the legislation will be implemented in practice. Key provisions include adjustments to areas such as age verification requirements and regulatory oversight, reflecting recommendations from parliamentary committees and ongoing consultations. The acceptance of these amendments signals broad political support for tightening controls on tobacco and vaping products, particularly in response to concerns about youth uptake. At the same time, debate continues over the potential impact of the measures on adult smokers and the role of harm reduction.